GYRE THERAPEUTICS, INC. Quarterly Common Stock, Shares, Outstanding from Q4 2010 to Q2 2024

Taxonomy & unit
us-gaap: shares
Description
Number of shares of common stock outstanding. Common stock represent the ownership interest in a corporation.
Summary
Gyre Therapeutics, Inc. quarterly Common Stock, Shares, Outstanding history and growth rate from Q4 2010 to Q2 2024.
  • Gyre Therapeutics, Inc. Common Stock, Shares, Outstanding for the quarter ending June 30, 2024 was 85.5M shares, a 125% increase year-over-year.
Common Stock, Shares, Outstanding, Quarterly (shares)
Common Stock, Shares, Outstanding, YoY Quarterly Growth (%)
Period Value YoY Chg Change % Date Report Filed
Q2 2024 85.5M +47.6M +125% Jun 30, 2024 10-Q 2024-08-13
Q1 2024 85.4M +47.7M +126% Mar 31, 2024 10-Q 2024-05-13
Q4 2023 76.6M +13M +20.5% Dec 31, 2023 10-Q 2024-08-13
Q3 2023 38M +6.49M +20.6% Sep 30, 2023 10-Q 2023-10-26
Q2 2023 38M +6.5M +20.6% Jun 30, 2023 10-Q 2023-08-14
Q1 2023 37.8M +6.28M +20% Mar 31, 2023 10-Q 2023-05-15
Q4 2022 63.6M +32.2M +102% Dec 31, 2022 10-K 2024-03-27
Q3 2022 31.5M +9.39M +42.5% Sep 30, 2022 10-Q 2022-11-14
Q2 2022 31.5M +127K +0.41% Jun 30, 2022 10-Q 2022-08-15
Q1 2022 31.5M +146K +0.47% Mar 31, 2022 10-Q 2022-05-09
Q4 2021 31.4M +9.31M +42.1% Dec 31, 2021 10-K 2023-03-30
Q3 2021 22.1M +14.9K +0.07% Sep 30, 2021 10-Q 2021-11-12
Q2 2021 31.3M +9.3M +42.2% Jun 30, 2021 10-Q 2021-08-05
Q1 2021 31.3M +13.9M +79.9% Mar 31, 2021 10-Q 2021-05-06
Q4 2020 22.1M +10.1M +83.5% Dec 31, 2020 10-K 2022-03-31
Q3 2020 22.1M +10.1M +83.6% Sep 30, 2020 10-Q 2020-11-05
Q2 2020 22.1M +10M +83.6% Jun 30, 2020 10-Q 2020-08-06
Q1 2020 17.4M +5.45M +45.5% Mar 31, 2020 10-Q 2020-05-11
Q4 2019 12M +86.3K +0.72% Dec 31, 2019 10-K 2021-03-04
Q3 2019 12M +87.3K +0.73% Sep 30, 2019 10-Q 2019-11-07
Q2 2019 12M +65.8K +0.55% Jun 30, 2019 10-Q 2019-08-01
Q1 2019 12M +39K +0.33% Mar 31, 2019 10-Q 2019-05-02
Q4 2018 12M +5.87M +96.6% Dec 31, 2018 10-K 2020-02-20
Q3 2018 11.9M +7.63M +177% Sep 30, 2018 10-Q 2018-11-01
Q2 2018 11.9M +7.63M +177% Jun 30, 2018 10-Q 2018-08-02
Q1 2018 11.9M +10.9M +1093% Mar 31, 2018 10-Q 2018-05-03
Q4 2017 6.08M +5.28M +658% Dec 31, 2017 10-K 2019-03-08
Q3 2017 4.31M -7.63M -63.9% Sep 30, 2017 10-Q 2017-11-02
Q2 2017 4.31M -7.19M -62.5% Jun 30, 2017 10-Q 2017-08-03
Q1 2017 1M -10.4M -91.3% Mar 31, 2017 10-Q 2017-05-11
Q4 2016 802K +39.8K +5.22% Dec 31, 2016 10-K 2018-03-19
Q3 2016 11.9M +524K +4.59% Sep 30, 2016 10-Q 2016-11-03
Q2 2016 11.5M +1.69M +17.3% Jun 30, 2016 10-Q 2016-08-04
Q1 2016 11.4M -22.4M -66.3% Mar 31, 2016 10-Q 2016-05-05
Q4 2015 762K +391K +105% Dec 31, 2015 10-K 2017-03-08
Q3 2015 11.4M -22.4M -66.2% Sep 30, 2015 10-Q 2015-11-05
Q2 2015 9.81M -24M -71% Jun 30, 2015 8-K/A 2015-10-23
Q1 2015 33.9M +87.7K +0.26% Mar 31, 2015 10-Q 2015-05-07
Q4 2014 371K -9.19M -96.1% Dec 31, 2014 10-K 2016-03-09
Q3 2014 33.8M +135K +0.4% Sep 30, 2014 10-Q 2014-11-06
Q2 2014 33.8M +157K +0.47% Jun 30, 2014 10-Q 2014-08-07
Q1 2014 33.8M +168K +0.5% Mar 31, 2014 10-Q 2014-05-08
Q4 2013 9.56M -24.1M -71.6% Dec 31, 2013 8-K/A 2015-10-23
Q3 2013 33.7M +52.1K +0.16% Sep 30, 2013 10-Q 2013-11-06
Q2 2013 33.6M +208K +0.62% Jun 30, 2013 10-Q 2013-08-07
Q1 2013 33.6M +219K +0.66% Mar 31, 2013 10-Q 2013-05-08
Q4 2012 33.6M +232K +0.69% Dec 31, 2012 10-K 2014-03-14
Q3 2012 33.6M +228K +0.68% Sep 30, 2012 10-Q 2012-11-08
Q2 2012 33.4M +56.6K +0.17% Jun 30, 2012 10-Q 2012-08-09
Q1 2012 33.4M Mar 31, 2012 10-Q 2012-05-09
Q4 2011 33.4M +4.51M +15.6% Dec 31, 2011 10-K 2013-03-15
Q3 2011 33.4M Sep 30, 2011 10-Q 2011-11-03
Q2 2011 33.4M Jun 30, 2011 10-Q 2011-08-09
Q4 2010 28.9M Dec 31, 2010 10-K 2012-03-06
* An asterisk sign (*) next to the value indicates that the value is likely invalid.